Shipeng Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 10%
Papers in
-
- Heme Oxygenase-1 and Carbon Monoxide 5
- Inflammasome and immune disorders 3
- Epidemiology 13
- Autophagy in Disease and Therapy 11
- Co-authors
- Neil D. Goldman (1 shared paper)Jindan He (6 shared papers)Rongxin Zhang (4 shared papers)Yao Yu (2 shared papers)Haiming Zhang (13 shared papers)Haixu Xu (2 shared papers)Jianjun Zhang (2 shared papers)Changying Wang (1 shared paper)
- Journals
- Journal of Cellular Biochemistry (5 papers)International Immunopharmacology (5 papers)Frontiers in Immunology (4 papers)Oncotarget (3 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shipeng Li
58 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 377
- Hepatology 92
- Molecular Biology 498
- Epidemiology 221
- Immunology 135
Countries citing papers authored by Shipeng Li
This map shows the geographic impact of Shipeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipeng Li more than expected).
Fields of papers citing papers by Shipeng Li
This network shows the impact of papers produced by Shipeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipeng Li. The network helps show where Shipeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shipeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 228 | |
| 2 | 1996 | 88 | |
| 3 | 2016 | 57 | |
| 4 | 2019 | 50 | |
| 5 | 2022 | 44 | |
| 6 | 2022 | 42 | |
| 7 | 2016 | 38 | |
| 8 | 2014 | 38 | |
| 9 | 2018 | 34 | |
| 10 | 2016 | 32 | |
| 11 | 2016 | 31 | |
| 12 | 2021 | 27 | |
| 13 | 2011 | 27 | |
| 14 | 2009 | 27 | |
| 15 | 2017 | 26 | |
| 16 | 2018 | 25 | |
| 17 | 2017 | 24 | |
| 18 | 2018 | 23 | |
| 19 | 2023 | 22 | |
| 20 | 2024 | 19 |
About Shipeng Li
Shipeng Li is a scholar working on Molecular Biology, Epidemiology, Immunology, Cancer Research and Surgery, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (11 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (8 papers), Immune Cell Function and Interaction (7 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers), Immune cells in cancer (4 papers), Inflammasome and immune disorders (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Cancer Research (377 citations), Hepatology (92 citations), Molecular Biology (498 citations), Epidemiology (221 citations) and Immunology (135 citations). Shipeng Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Neil D. Goldman, Jindan He, Rongxin Zhang, Yao Yu, Haiming Zhang, Haixu Xu, Jianjun Zhang, Changying Wang, Zhi Yao and Zhongyang Shen. Their work appears in journals such as Journal of Cellular Biochemistry, International Immunopharmacology, Frontiers in Immunology, Oncotarget and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.